Guest guest Posted November 9, 2008 Report Share Posted November 9, 2008 Arthritis Research & Therapy 2008, 10:218doi:10.1186/ar2488 Review Published: 10 October 2008 Developments in the scientific understanding of lupus P Ardoin1 and S Pisetsky2 1Departments of Pediatrics and Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA 2Medical Research Service, Durham VA Hospital, Durham, North Carolina, 508 Fulton Street, Durham, NC 27705, USA Abstract Systemic lupus erythematosus is a systemic autoimmune disease characterized by the production of antinuclear antibodies (ANAs). Recent research into human and murine lupus suggests that disease susceptibility results from genetic polymorphisms regulating immune responses as well as impairing the clearance of apoptotic cells. Because the products of dead cells, including nucleic acids, have immunologic activity, this situation can promote antigen-driven ANA responses. Furthermore, immune complexes of ANAs can drive the production of proinflammatory cytokines, inducing the 'interferon signature', and intensifying disease. Together, these findings point to new genetic and immunologic markers of disease as well as targets for new therapies. ************************************************* Read the full text here: http://arthritis-research.com/content/10/5/218 Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.